Skip to content

Hemashield Microvel Velour Knitted Vascular Graft

by Meadox Medicals, Div. Boston Scientific Corp.

510(k) K954848

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

6 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)ST Traditional NumberK954848 Date1 Feb 1996DecidedStatusActive

Recalls

6 recalls · FDA

    • Terminated Z-0729-2022 FDA Class II initiated 14 Jan 2022

    Outer labelling (HEMASHIELD GOLD Knitted Microvel Double Velour Bifurcated Vascular Graft, D: 16 x 8 mm; L: 40 cm) does not correspond to the (inner) sterile packaging labelling (HEMASHIELD GOLD Knitted Microvel Double Velour Straight Vascular Graft, D: 7 mm L: 60 cm). Mislabeled product could cause a disruption of the vascular anastomosis in the long term, creating a pseudo-aneurysm

    • Terminated Z-0403-2022 FDA Class II initiated 1 Dec 2021

    There is a probable mislabeling of product. A Hemashield Platinum Woven Double Velour Bifurcated Vasuclar Graft, SN 1259735369, 24 mm x 12 mm, REF Number M00202166241P0 is likely packaged inside of the carton instead of a Hemashield Gold Knitted Microvel Double Velour Bifurcated Vascular Graft; SN 1260004700; 18 mm x 9 mm; REF Number M002020851890 or a Hemashield Gold Knitted Microvel Double Velour Bifurcated Vascular Graft; SN 1259882880; 18 mm x 9 mm; Ref Number M002020851890.

  • 3 recalls, same reason

    • Terminated Z-1859-2020 FDA Class II initiated 7 Apr 2020
    • Terminated Z-1861-2020 FDA Class II initiated 7 Apr 2020
    • Terminated Z-1860-2020 FDA Class II initiated 7 Apr 2020

    Potential small holes at the seam lines of Hemashield branches causing intra-operative bleeding at the seam lines of the branches of Hemashield grafts

    • Terminated Z-2066-2010 FDA Unclassified (pre-2012) initiated 24 May 2010

    Various Hemashield products may develop glycerol droplets on the inner blister of the package if not stored under proper conditions, which could lead to the prolongation of surgery and potentially compromise patient safety.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
MAL
Device Class
Class II
Regulation
21 CFR Part 870.3450
Advisory Committee
Cardiovascular
FDA Decision
ST

Other devices from Meadox Medicals, Div. Boston Scientific Corp.

See all devices from Meadox Medicals, Div. Boston Scientific Corp. →